A feasibility study of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and IP paclitaxel in patients with epithelial ovarian carcinoma, fallopian tube carcinoma, or peritoneal carcinoma

被引：0
|
作者：
Nagao, S. [1 ]
Oishi, R. [1 ]
Iwasa, N. [1 ]
Shimizu, M. [1 ]
Hasegawa, K. [1 ]
Goto, T. [1 ]
Fujiwara, K. [1 ]
机构：
[1] Saitama Med Univ Int, Med Ctr, Hidaka City, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16549
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Intravenous (IV)/intraperitoneal (IP) paclitaxel and IP carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: A feasibility study.
    Nagao, S.
    Nishikawa, T.
    Kurosaki, A.
    Ohishi, R.
    Iwasa, N.
    Hasegawa, K.
    Fujiwara, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma A Feasibility Study
    Nagao, Shoji
    Iwasa, Norihiro
    Kurosaki, Akira
    Nishikawa, Tadaaki
    Ohishi, Rie
    Hasegawa, Kosei
    Goto, Tomoko
    Fujiwara, Keiichi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (01) : 70 - 75
  • [3] A feasibility study of intravenous (IV) paclitaxel, intrapertioneal (IP) carboplatin, and intraperitoneal paclitaxel (T CipTip theraphy) in patients with epithelial ovarian carcinoma
    Nagao, S.
    Nakagami, H.
    Tsukahara, S.
    Ohishi, R.
    Iwasa, N.
    Hasegawa, K.
    Fujiwara, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study
    Gould, Natalie
    Sill, Michael W.
    Mannel, Robert S.
    Thaker, P. H.
    DiSilvestro, Paul
    Waggoner, Steve
    Yamada, S. Diane
    Armstrong, Deborah K.
    Wenzel, Lari
    Huang, Helen
    Fracasso, Paula M.
    Walker, Joan L.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (01) : 54 - 58
  • [5] A phase I trial of intravenous paclitaxel, intraperitoneal carboplatin, and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study
    Gould, N.
    Sill, M.
    Mannel, R.
    Fracasso, P.
    Thaker, P.
    DiSilvestro, P.
    Waggoner, S.
    Yamada, S.
    Armstrong, D.
    Walker, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S15 - S15
  • [6] Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study
    Dizon, Don S.
    Sill, Michael W.
    Gould, Natalie
    Rubin, Stephen C.
    Yamada, S. Diane
    DeBernardo, Robert L.
    Mannel, Robert S.
    Eisenhauer, Eric L.
    Duska, Linda R.
    Fracasso, Paula M.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 182 - 186
  • [7] A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study
    Morgan, M.
    Sill, M.
    Fujiwara, K.
    Geer, B.
    Rubin, S.
    De Geest, K.
    Yamada, S.
    Waggoner, S.
    Coleman, R.
    Walker, J.
    Mannel, R.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S15 - S15
  • [8] A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study
    Morgan, Mark A.
    Sill, Michael W.
    Fujiwara, Keiichi
    Greer, Benjamin
    Rubin, Stephen C.
    DeGeest, Koen
    Yamada, S. Diane
    Waggoner, Steven
    Coleman, Robert L.
    Walker, Joan L.
    Mannel, Robert S.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (02) : 264 - 268
  • [9] Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: Gynecologic Oncology Group study 9921.
    Dizon, D. S.
    Sill, M.
    Gould, N. S.
    Rubin, S. C.
    Yamada, S. D.
    DeBernardo, R.
    Mannel, R. S.
    Eisenhauer, E. L.
    Duska, L. R.
    Fracasso, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study
    Gould, Natalie
    Sill, Michael W.
    Mannel, Robert S.
    Thaker, Premal
    DiSilvestro, Paul A.
    Waggoner, Steven E.
    Yamada, S. Diane
    Armstrong, Deborah K.
    Fracasso, Paula M.
    Walker, Joan L.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (03) : 506 - 510
12345